Pramodini Medicare Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
The Initial Public Offering of Pramodini Medicare Limited's culminated in its successful listing on Aug 19, 2026 at the NSE trading platform. The company secured 58,51,200 Shares through this capital market exercise, with 53,50,800 Shares allocated to new capital formation and ₹5.90 Cr to existing shareholder liquidity.
Investors participated within the price parameters of ₹110 to ₹118, with minimum investment requirements of 1200 shares. The subscription period from Aug 12, 2026 to Aug 14, 2026 witnessed active investor engagement across categories.
Following the subscription closure, share allotment was processed on Aug 17, 2026. The subsequent listing established a public market for the company's shares, enabling price discovery and secondary market trading for investors.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Pramodini Medicare Limited, incorporated in 2000, is a technology-enabled diagnostic healthcare company providing radiology, clinical laboratory, and nuclear medicine services across India. The company offers a wide range of diagnostic solutions, including MRI, CT scans, X-rays, ultrasound, mammography, pathology, microbiology, biochemistry, PET-CT, SPECT, and nuclear medicine services. It serves government and private hospitals, public sector undertakings (PSUs), medical colleges, and standalone diagnostic centres through multiple partnership models. With a network of diagnostic centres, a 24×7 teleradiology facility, and advanced healthcare technology, Pramodini Medicare focuses on delivering accurate, reliable, and accessible diagnostic services across Tier I, II, and III cities.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strategic Multi-State Presence: The company operates a network of diagnostic centres across multiple states, serving both government and private healthcare institutions.
- Diversified Business Model: It operates through PPP projects, private hospital partnerships, PSU collaborations, and standalone diagnostic centres, reducing dependence on a single business model.
- Strong Technical & IT Infrastructure: The company uses advanced IT systems to support radiology, laboratory, nuclear medicine, and 24×7 teleradiology services, improving operational efficiency and patient care.
- Dependence on Government PPP Contracts: A significant portion of the company's revenue comes from government PPP projects. Non-renewal of contracts or payment delays could affect business performance.
- High Reliance on Radiology Services: The company earns a large share of its revenue from radiology services. Any slowdown in this segment could impact revenue and profitability.
- Geographical Concentration Risk: A significant portion of the company's revenue comes from Andhra Pradesh. Any adverse developments in this state could affect business operations and financial performance.
- Chalasani Durga Aashritha
- Chalasani Kavitha
- Chalasani Kuldeep Kumar
- Chalasani Lalithakumar
- Sri Ram Medicare Pvt. Ltd.
Pramodini Medicare Limited
Purva Sharegistry India Private Limited